Influence of Hepatocellular Senescence on Serum Amyloid A Expression and Response to Proinflammatory Cytokines under Steatotic Conditions
Abstract
Serum amyloid A (SAA) is an apolipoprotein produced mainly by the liver. SAA1 is upregulated during inflammation, whereas SAA4 is constitutively expressed and is generally considered to be unresponsive to proinflammatory cytokines. However, SAA4 has been identified as a gene whose expression increases in senescent hepatocytes. Cellular senescence has been implicated in the onset and progression of hepatic steatosis. This study aimed to clarify how cellular senescence influences SAA expression and cytokine responsiveness under steatotic conditions. An in vitro senescence-like model was established using HepG2 cells treated with doxorubicin. SAA4 transcript and secreted protein levels were upregulated in senescent cells, whereas SAA1 transcript levels remained very low. Senescent cells exhibited spontaneous lipid accumulation and an excessive response to oleic acid treatment. However, steatotic conditions did not alter the SAA4 transcript levels in either control or senescent cells. This result indicates that the upregulation of SAA4 persists independently of steatotic conditions. Proinflammatory cytokines robustly induced SAA1 expression and modestly increased SAA4 expression in control cells, amplifying these responses under lipid accumulation. Notably, senescence attenuated SAA induction in response to these cytokines, regardless of lipid accumulation. Although these findings were obtained in HepG2 cells, they provide a clue to understanding the regulation of SAA expression under non-basal conditions relevant to age-related liver diseases.
Related
- DCTN2 inhibited cellular senescence through targeting TRIM21 mediated MST2 ubiquitination and activation in hepatocellular carcinoma.
- Potential Influence of NUCB2 Genetic Variants on the Clinicopathological Features of Patients with Hepatocellular Carcinoma
- Methylation-associated Gene Expression (MaGE): a non-invasive, in vivo measure of cellular senescence.
- DNA damage response as a driver of PD-L1 expression in cellular senescence: implications for immune evasion and immunosenescence
- Gilteritinib Suppresses Hepatocellular Carcinoma Cells in Association with Reduced Calpain-1 Expression and Inhibition of STAT3/AKT Signaling
BibTeX
@article{takarada2026influence,
title = {{Influence of Hepatocellular Senescence on Serum Amyloid A Expression and Response to Proinflammatory Cytokines under Steatotic Conditions}},
author = {Toru Takarada and Masaki Shimada and Izumi Omura and Toshiyuki Yamada and Masafumi Tanaka},
journal = {Biological and Pharmaceutical Bulletin},
year = {2026},
month = oct,
doi = {10.1248/bpb.b26-00351},
url = {https://www.jstage.jst.go.jp/article/bpb/49/10/49_b26-00351/_article},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - Influence of Hepatocellular Senescence on Serum Amyloid A Expression and Response to Proinflammatory Cytokines under Steatotic Conditions
AU - Toru Takarada
AU - Masaki Shimada
AU - Izumi Omura
AU - Toshiyuki Yamada
AU - Masafumi Tanaka
PY - 2026
DA - 2026/10/08
JO - Biological and Pharmaceutical Bulletin
DO - 10.1248/bpb.b26-00351
UR - https://www.jstage.jst.go.jp/article/bpb/49/10/49_b26-00351/_article
AB - Serum amyloid A (SAA) is an apolipoprotein produced mainly by the liver. SAA1 is upregulated during inflammation, whereas SAA4 is constitutively expressed and is generally considered to be unresponsive to proinflammatory cytokines. However, SAA4 has been identified as a gene whose expression increases in senescent hepatocytes. Cellular senescence has been implicated in the onset and progression of hepatic steatosis. This study aimed to clarify how cellular senescence influences SAA expression and cytokine responsiveness under steatotic conditions. An in vitro senescence-like model was established using HepG2 cells treated with doxorubicin. SAA4 transcript and secreted protein levels were upregulated in senescent cells, whereas SAA1 transcript levels remained very low. Senescent cells exhibited spontaneous lipid accumulation and an excessive response to oleic acid treatment. However, steatotic conditions did not alter the SAA4 transcript levels in either control or senescent cells. This result indicates that the upregulation of SAA4 persists independently of steatotic conditions. Proinflammatory cytokines robustly induced SAA1 expression and modestly increased SAA4 expression in control cells, amplifying these responses under lipid accumulation. Notably, senescence attenuated SAA induction in response to these cytokines, regardless of lipid accumulation. Although these findings were obtained in HepG2 cells, they provide a clue to understanding the regulation of SAA expression under non-basal conditions relevant to age-related liver diseases.
SN - 1347-5215
SN - 0918-6158
ER -